February 28 – March 1, 2017 | San Francisco





Partnership Opportunities

The Novel Cardiovascular Therapeutics Summit 2017 will host the key stakeholders in cardiovascular drug development (pharma, biotech and academia) to discuss the latest breakthroughs and developments in cardiovascular pharmacotherapy approaches.

Our attendees are actively seeking outside expertise, collaborators and partners to help them with:

  • Accelerating pre-clinical research with better in vitro and in vivo models of CVD, improved assays, more efficient safety and efficacy testing
  • Streamlining and optimizing clinical trial design, managing the rigorous standards demanded in cardiovascular trials, accessing patient populations
  • Improving data collection with advanced cardiovascular imaging, cardiac monitoring and central processing of CV images to comply with regulatory guidelines and requirements

This is an unparalleled opportunity to showcase your capabilities and therapeutic expertise in the cardiovascular space, and establish your credibility as a research partner to enhance the drug development process.

If you have a product of service that would help this market, register your interest below or contact our Commercial Manager at sponsor@hansonwade.com to discuss how we can help you reach this audience.

register your interest dark red